Syros(SYRS) - 2022 Q4 - Earnings Call Transcript

Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Q4 2022 Earnings Conference Call March 2, 2023 8:30 AM ET Company Participants Karen Hunady - Director-Investor Relations & Corporate Communications Nancy Simonian - Chief Executive Officer David Roth - Chief Medical Officer Jason Haas - Chief Financial Officer Conference Call Participants Philip Nadeau - Cowen and Company Mark Breidenbach - Oppenheimer Jason Butler - JMP Securities Operator Good morning, and welcome to Syros Pharmaceuticals Fourth Quarter and Full ...